Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Vistagen Therapeutics (VTGN) Tax Provisions (2017 - 2024)

Historic Tax Provisions for Vistagen Therapeutics (VTGN) over the last 12 years, with Q3 2024 value amounting to $7000.0.

  • Vistagen Therapeutics' Tax Provisions changed N/A to $7000.0 in Q3 2024 from the same period last year, while for Jun 2025 it was $7000.0, marking a year-over-year increase of 60000.0%. This contributed to the annual value of $7000.0 for FY2025, which is 7500.0% up from last year.
  • According to the latest figures from Q3 2024, Vistagen Therapeutics' Tax Provisions is $7000.0.
  • Vistagen Therapeutics' 5-year Tax Provisions high stood at $7000.0 for Q3 2024, and its period low was $200.0 during Q3 2020.
  • Over the past 5 years, Vistagen Therapeutics' median Tax Provisions value was $3000.0 (recorded in 2020), while the average stood at $2744.4.
  • As far as peak fluctuations go, Vistagen Therapeutics' Tax Provisions skyrocketed by 8333.33% in 2022, and later tumbled by 4545.45% in 2023.
  • Over the past 5 years, Vistagen Therapeutics' Tax Provisions (Quarter) stood at $200.0 in 2020, then surged by 1400.0% to $3000.0 in 2021, then skyrocketed by 83.33% to $5500.0 in 2022, then crashed by 45.45% to $3000.0 in 2023, then surged by 133.33% to $7000.0 in 2024.
  • Its last three reported values are $7000.0 in Q3 2024, $1000.0 for Q1 2024, and $3000.0 during Q2 2023.